Glycemic Control With Novel Once-Weekly Basal Insulin Fc vs Insulin Degludec Therapy in Patients With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
Diabetes Care 2023 May 01;46(5)1052-1059, CM Kazda, JM Bue-Valleskey, J Chien, Q Zhang, E Chigutsa, W Landschulz, P Wullenweber, A Haupt, D DahlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.